Sánchez Mirna L, Valdez Hugo, Conde Micaela, Viaña-Mendieta Pamela, Boccaccini Aldo R
Laboratorio de Farmacología Molecular, Departamento de Ciencia y Tecnología, Universidad Nacional de Quilmes, Bernal B1876, Argentina.
Institute of Biomaterials, Department of Materials Science and Engineering, University of Erlangen-Nuremberg, Cauerstrasse 6, 91058 Erlangen, Germany.
Pharmaceutics. 2023 Jun 5;15(6):1655. doi: 10.3390/pharmaceutics15061655.
The development of biomaterial platforms for dispensing reagents of interest such as antioxidants, growth factors or antibiotics based on functional hydrogels represents a biotechnological solution for many challenges that the biomedicine field is facing. In this context, in situ dosing of therapeutic components for dermatological injuries such as diabetic foot ulcers is a relatively novel strategy to improve the wound healing process. Hydrogels have shown more comfort for the treatment of wounds due to their smooth surface and moisture, as well as their structural affinity with tissues in comparison to hyperbaric oxygen therapy, ultrasound, and electromagnetic therapies, negative pressure wound therapy or skin grafts. Macrophages, one of the most important cells of the innate immune system, have been described as the key not only in relation to the host immune defense, but also in the progress of wound healing. Macrophage dysfunction in chronic wounds of diabetic patients leads to a perpetuating inflammatory environment and impairs tissue repair. Modulating the macrophage phenotype from pro-inflammatory (M1) to anti-inflammatory (M2) could be a strategy for helping to improve chronic wound healing. In this regard, a new paradigm is found in the development of advanced biomaterials capable of inducing in situ macrophage polarization to offer an approach to wound care. Such an approach opens a new direction for the development of multifunctional materials in regenerative medicine. This paper surveys emerging hydrogel materials and bioactive compounds being investigated to induce the immunomodulation of macrophages. We propose four potential functional biomaterials for wound healing applications based on novel biomaterial/bioactive compound combination that are expected to show synergistic beneficial outcomes for the local differentiation of macrophages (M1-M2) as a therapeutic strategy for chronic wound healing improvement.
基于功能性水凝胶开发用于分配抗氧化剂、生长因子或抗生素等目标试剂的生物材料平台,为生物医学领域面临的许多挑战提供了一种生物技术解决方案。在这种背景下,对糖尿病足溃疡等皮肤损伤进行治疗成分的原位给药是改善伤口愈合过程的一种相对新颖的策略。与高压氧治疗、超声、电磁疗法、负压伤口治疗或皮肤移植相比,水凝胶因其光滑的表面和湿润性,以及与组织的结构亲和力,在伤口治疗中显示出更高的舒适度。巨噬细胞是先天免疫系统最重要的细胞之一,不仅在宿主免疫防御方面,而且在伤口愈合进程中都被描述为关键因素。糖尿病患者慢性伤口中的巨噬细胞功能障碍会导致炎症环境持续存在,并损害组织修复。将巨噬细胞表型从促炎(M1)调节为抗炎(M2)可能是帮助改善慢性伤口愈合的一种策略。在这方面,在能够诱导原位巨噬细胞极化的先进生物材料的开发中发现了一种新的范例,为伤口护理提供了一种方法。这种方法为再生医学中多功能材料的开发开辟了新的方向。本文综述了正在研究的用于诱导巨噬细胞免疫调节的新型水凝胶材料和生物活性化合物。我们基于新型生物材料/生物活性化合物组合提出了四种用于伤口愈合应用的潜在功能性生物材料,预期它们对巨噬细胞(M1 - M2)的局部分化将产生协同有益效果,作为改善慢性伤口愈合的治疗策略。